Abstract 1798: Glyoxalase 1 (GLO1) as an oncometabolic enabler of prostate cancer progression: CRISPR/Cas9-based GLO1-deletion from human DU145-Luc2 cells blocks EMT and bone metastasis in SCID mice
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Jana Jandova, Anne E. Cress, Georg T. Wondrak
Institutions: University of Arizona, University of Arizona Cancer Center
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4393088904